<div><p>Background/Objectives</p><p>This study aimed to examine socioeconomic inequalities in the prevalence of biomarkers of cardiovascular disease and diabetes in the newly developed large-scale genomic cohort study of Korean adults, the Health Examinees-Gem (HEXA-G), with a comparison of the nationally representative cross-sectional study, the Korea National Health and Nutrition Examination Survey (K-NHANES).</p><p>Subjects/Methods</p><p>Using the HEXA-G and the K-NHANES from 2007–2012, we analyzed the age-adjusted relative risk (RR) and prevalence of enlarged waist circumference (EWC), elevated triglycerides (ET), low HDL cholesterol (LHC), elevated blood pressure (EBP) and elevated blood glucose (EBG) by income and educational groups f...
Background: Socioeconomic inequalities in cardiovascular (CVD) health outcomes are well documented. ...
OBJECTIVE—The number of people with metabolic syndrome is increasing worldwide, and changes in socio...
Abstract Background Abnormalities in the clinical markers of metabolic syndrome (MS) are associated ...
This study aimed to examine socioeconomic inequalities in the prevalence of biomarkers of cardiovasc...
Background Most of the evidence about socioeconomic inequalities in the metabolic syndrome comes fro...
Background : The purpose of this study was to investigate how educational status influences cardiova...
AIMS: To investigate sex differences in the relationship between socioeconomic status (SES) and the ...
PURPOSE: To estimate the prevalence of cardiovascular risk factors in South Korea. METHODS: Data we...
BACKGROUND:To investigate the effects of age and sex on the relationship between socioeconomic statu...
Background Unlike the older birth cohort (1943-65), the younger birth cohort (1966-79) has enjoyed m...
<div><p>Background</p><p>The prevalence of metabolic syndrome has markedly increased worldwide. Howe...
To investigate the effects of age and sex on the relationship between socioeconomic status (SES) and...
Objective: To examine age-specific patterns in the ability of major cardiovascular risk factors to e...
In the general population, males show increased cardiovascular disease prevalence compared to female...
BACKGROUND: Socioeconomic inequalities in cardiovascular (CVD) health outcomes are well documented. ...
Background: Socioeconomic inequalities in cardiovascular (CVD) health outcomes are well documented. ...
OBJECTIVE—The number of people with metabolic syndrome is increasing worldwide, and changes in socio...
Abstract Background Abnormalities in the clinical markers of metabolic syndrome (MS) are associated ...
This study aimed to examine socioeconomic inequalities in the prevalence of biomarkers of cardiovasc...
Background Most of the evidence about socioeconomic inequalities in the metabolic syndrome comes fro...
Background : The purpose of this study was to investigate how educational status influences cardiova...
AIMS: To investigate sex differences in the relationship between socioeconomic status (SES) and the ...
PURPOSE: To estimate the prevalence of cardiovascular risk factors in South Korea. METHODS: Data we...
BACKGROUND:To investigate the effects of age and sex on the relationship between socioeconomic statu...
Background Unlike the older birth cohort (1943-65), the younger birth cohort (1966-79) has enjoyed m...
<div><p>Background</p><p>The prevalence of metabolic syndrome has markedly increased worldwide. Howe...
To investigate the effects of age and sex on the relationship between socioeconomic status (SES) and...
Objective: To examine age-specific patterns in the ability of major cardiovascular risk factors to e...
In the general population, males show increased cardiovascular disease prevalence compared to female...
BACKGROUND: Socioeconomic inequalities in cardiovascular (CVD) health outcomes are well documented. ...
Background: Socioeconomic inequalities in cardiovascular (CVD) health outcomes are well documented. ...
OBJECTIVE—The number of people with metabolic syndrome is increasing worldwide, and changes in socio...
Abstract Background Abnormalities in the clinical markers of metabolic syndrome (MS) are associated ...